Spots Global Cancer Trial Database for A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
Official Title: A Phase III Confirmatory Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia and Pain
Study ID: NCT05445167
Study Description
Brief Summary: Multi-center, randomized, double-blind, parallel-group study to confirm superiority of KLH-2109 to placebo in uterine fibroids patient with menorrhagia and pain
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Clinical Research Site, Multiple Locations, , Japan
Contact Details
Name: Yoshitaka Shimizu
Affiliation: Kissei Pharmaceutical Co., Ltd.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
